2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 5g

5-(Aminomethyl)-3-(4-fluorophenyl)-1,3-oxazolidin-2-one hydrochloride, 95.0%, 500mg

3,3-Bis(4-hydroxynaphthalen-1-yl)isobenzofuran-1(3H)-one, 97%, 25g

(4-(3-Chloropropoxy)phenyl)boronic acid, 95+%, 500mg

(1-(Tetrahydro-2H-pyran-2-yl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)boronic acid, 95.0%, 100mg

(11bR)-N,N-Bis((1S)-1-phenylethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98.0%, 5g

Pipette microlitre monocanal Transferpette® S variable, 100 à 1000 µl, D-1000, 1 pièce

(E)-2-(6-Chlorohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

BENZBROMARONE, 95%, 250mg

4-hydroxy-5-methoxy-2-pyridinecarboxylic acid hydrate, 95.0%, 1g

2-Amino-3-methoxypyridine, 95.0%, 100g

Sulfonfluorescein>75.0%(HPLC)(T)5g